Medication following bariatric surgery for type 2 diabetes mellitus
Research type
Research Study
Full title
Medication following bariatric surgery for type 2 diabetes mellitus
IRAS ID
271669
Contact name
Alex Miras
Contact email
Sponsor organisation
Imperial College London
Clinicaltrials.gov Identifier
Duration of Study in the UK
6 years, 0 months, 1 days
Research summary
The aim of this study is to investigate the continued usage of standard diabetes medications in the post operative period following bariatric surgery to determine whether this approach may improve long term diabetes control. At present, the standard of treatment in patients with type 2 diabetes is that all medication is stopped in the immediate postoperative period and only re-started if symptoms of diabetes re-emerge. Although a large proportion of patients with diabetes will initially go in to remission, 80% experience relapse within five years. This study is needed to determine whether continuing medications is not only safe but will improve long term outcomes for patients with diabetes.
REC name
London - Fulham Research Ethics Committee
REC reference
20/LO/1156
Date of REC Opinion
8 Dec 2020
REC opinion
Further Information Favourable Opinion